Cognitive / Neuro · Research guide

Dihexa peptide: Cognitive / Neuro research guide

Catalogue reference · Laboratory research only

Not medical advice. Dihexa is sold for research. This guide does not recommend dosing, diagnosis, or therapy.

Dihexa is listed in our catalogue under “Cognitive / Neuro.” In scientific publications it is discussed in technical language; this page translates the general themes into everyday wording while staying faithful to research-only framing.

Plain-language snapshot

One-paragraph overview from our research datasheet—still scientific, but faster to read than the full mechanism list below.

Dihexa (PNB-0408) is an orally active angiotensin IV-derived peptidomimetic that potentiates HGF/c-Met signaling to drive hippocampal synaptogenesis.

What shows up in scientific writing (general background)

Many readers want context before diving into pathways. The list below summarises what researchers and reviewers discuss—cells, animals, and (for some drug-class molecules) formal clinical trials. It is not a promise of results for any individual.

“Reported” means described in the literature, not recommended for personal use. Our peptides are for laboratory research only.

Typical study contexts & reported directions

Stress, sleep, and neuronal signalling in rodents; peptide tools for probing pathways, not treating human cognition.
Some compounds appear in small exploratory human studies elsewhere in the literature—still distinct from DIY use.
Peer-reviewed preclinical work sometimes describes experiments that track whether binds HGF with picomolar affinity (Kd = 65 pM) to allosterically potentiate c-Met receptor activation
Peer-reviewed preclinical work sometimes describes experiments that track whether promotes hippocampal spinogenesis and synaptogenesis—7 orders of magnitude more potent than BDNF in vitro
Peer-reviewed preclinical work sometimes describes experiments that track whether reverses scopolamine-induced and age-related cognitive deficits in preclinical spatial memory tasks
Peer-reviewed preclinical work sometimes describes experiments that track whether blood-brain barrier permeable with brain-to-plasma concentration ratio exceeding 1.0 in rodent PK studies

Why Cognitive / Neuro research discusses this compound

Cognitive-related peptides are explored for stress-response pathways, neuronal signalling, and behaviour in animal models -not as treatments for human brain conditions.

Themes from preclinical literature (technical)

Below are mechanistic bullet points as they appear in our product reference material -useful for researchers comparing pathways. They are not simplified health claims.

Binds HGF with picomolar affinity (Kd = 65 pM) to allosterically potentiate c-Met receptor activation
Promotes hippocampal spinogenesis and synaptogenesis—7 orders of magnitude more potent than BDNF in vitro
Reverses scopolamine-induced and age-related cognitive deficits in preclinical spatial memory tasks
Blood-brain barrier permeable with brain-to-plasma concentration ratio exceeding 1.0 in rodent PK studies
Orally bioavailable—predicted jejunal permeability comparable to established oral drugs (enalapril, piroxicam)
Activates downstream PI3K/AKT neuroprotective signaling cascade

Typical handling notes (from our datasheet)

Storage: Store in cool, dry place. Stable at room temperature when dry. - see our storage guide for best practices on temperature, light, and shelf life.

Typical research dosing discussion (literature-style): 10–20 mg oral or subcutaneous · Once daily, morning administration on empty stomach · Rat IV t½ = 12.68 days; rat IP t½ = 8.83 days (McCoy et al., 2013). Extensive tissue distribution with large Vd. QSAR-calculated log P (octanol/water partition coefficient) = 177.8 indicating high lipophilicity. Predicted human jejunal permeability (Peff = 1.78) intermediate between enalapril and piroxicam. MW 504.66 Da permits passive BBB diffusion. CAUTION: HGF/c-Met pathway is an established oncological target—chronic activation carries theoretical carcinogenic risk.

For preparation, follow the step-by-step reconstitution guide and use the reconstitution calculator to confirm draw volumes. Review subcutaneous injection basics for technique, and always verify batch purity by reading the COA.

Frequently asked questions

What is Dihexa in plain language?
Dihexa is a research peptide we catalogue under “Cognitive / Neuro.” This article explains how scientists discuss it in published literature and what study types usually appear—not as a consumer product claim.

Does this page give medical advice or dosing instructions for Dihexa?
No. Content is for laboratory and research literacy only. It does not diagnose, treat, or prevent disease, and is not a dosing guide.

Where can I see purity, variants, and pricing for Dihexa?
Use the “View product” button to open the canonical shop listing for Dihexa, where specifications and research SKU details are shown.

What about online case reports, before-and-after stories, or forum “logs” for Dihexa?
Those sources are not peer-reviewed evidence. This guide focuses on preclinical literature and, where relevant, formal clinical trial programmes for drug-class molecules. Anecdotes may be interesting culturally; they are not a safe basis for dosing or medical decisions.

Need vial specs & pricing?

Open the shop listing for variants, purity notes, and research SKU details.

View product

Also known as: Dihexa, PNB-0408, N-Hexanoic-Tyr-Ile-(6)-aminohexanoic Amide, Angiotensin IV Analog, HGF Potentiator, c-Met Activator